.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Chubb
Teva
Express Scripts
Chinese Patent Office
Fish and Richardson
Daiichi Sankyo
Baxter
Covington
Boehringer Ingelheim

Generated: June 23, 2017

DrugPatentWatch Database Preview

ERYTHROMYCIN LACTOBIONATE Drug Profile

« Back to Dashboard

What is the patent landscape for Erythromycin Lactobionate, and when can generic versions of Erythromycin Lactobionate launch?

Erythromycin Lactobionate is a drug marketed by Abraxis Pharm, Teva Parenteral, and Baxter Hlthcare. and is included in three NDAs.

The generic ingredient in ERYTHROMYCIN LACTOBIONATE is erythromycin lactobionate. There are ninety-eight drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the erythromycin lactobionate profile page.

Summary for Tradename: ERYTHROMYCIN LACTOBIONATE

Patents:0
Applicants:3
NDAs:3
Bulk Api Vendors: see list10
Clinical Trials: see list92
Patent Applications: see list764
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ERYTHROMYCIN LACTOBIONATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm
ERYTHROMYCIN LACTOBIONATE
erythromycin lactobionate
INJECTABLE;INJECTION062604-002Nov 24, 1986DISCNNoNo► Subscribe► Subscribe
Teva Parenteral
ERYTHROMYCIN LACTOBIONATE
erythromycin lactobionate
INJECTABLE;INJECTION063253-001Jul 30, 1993DISCNNoNo► Subscribe► Subscribe
Abraxis Pharm
ERYTHROMYCIN LACTOBIONATE
erythromycin lactobionate
INJECTABLE;INJECTION062604-001Nov 24, 1986DISCNNoNo► Subscribe► Subscribe
Teva Parenteral
ERYTHROMYCIN LACTOBIONATE
erythromycin lactobionate
INJECTABLE;INJECTION063253-002Jul 30, 1993DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
ERYTHROMYCIN LACTOBIONATE
erythromycin lactobionate
INJECTABLE;INJECTION062993-001May 9, 1989DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Queensland Health
Chubb
McKinsey
Fish and Richardson
US Department of Justice
Daiichi Sankyo
Covington
Boehringer Ingelheim
Fuji
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot